Navigation Links
Favrille to Present at AG Edwards Emerging Growth Conference and Wall Street Analyst Forum
Date:9/10/2007

Live Webcasts from New York on September 18th and 20th

SAN DIEGO, Sept. 10 /PRNewswire-FirstCall/ -- Favrille, Inc. (Nasdaq: FVRL), a biopharmaceutical company developing patient-specific, active immunotherapies for the treatment of cancer, today announced that Tamara Seymour, Chief Financial Officer, and David Guy, Chief Commercial Officer, will present at two upcoming investor conferences:

-- AG Edwards Emerging Growth Conference at 1:00 p.m. Eastern time on

Tuesday, September 18, 2007, from the New York Palace Hotel in New

York City; and

-- Wall Street Analyst Forum at 9:10 a.m. Eastern time on Thursday,

September 20, 2007, from the Princeton Club in New York City.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031013/LAM095LOGO)

Live webcasts of both presentations can be accessed at http://www.favrille.com. Replays will be available approximately one hour after each presentation and archived for one month.

About Favrille, Inc.

Favrille, Inc. is a biopharmaceutical company focused on the development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system. The Company's lead product candidate, FavId, is based upon unique genetic information extracted from a patient's tumor. FavId is currently under investigation in a pivotal Phase 3 clinical trial for patients with follicular B-cell NHL and Phase 2 clinical trials in other B-cell NHL indications. The Company is developing additional applications based on its immunotherapy expertise and proprietary cost-effective manufacturing technology, including a second product candidate, FAV-201, for the treatment of cutaneous T-cell lymphoma.


'/>"/>
SOURCE Favrille, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)... -- Intarcia Therapeutics, Inc. delivered two pres...nuous delivery of exenatide) program for the treat...es Technology Meeting in San Francisco, CA: ,, ...01/SFTU126LOGO ) ,, Continuous Subcutaneous D...ucose, HbA1c and Reduces Weight in a 28-day Phase ...
(Date:11/5/2009)... , Fuel economy ratings for the new 2010 model y...nomy.gov web site, which Oak Ridge National Labor...ent of Energy and the U.S. Environmental Protectio...fuel economy list are hybrid electrics, led by the...t proves that hybrids have gone mainstream," said ...
(Date:11/5/2009)...e/ -- The endangered black-footed ferrets inhabit ...arnivore feeds on prairie dogs. The prairie dogs...opulation die-offs in towns occur. The U.S. Fish ...ret breeding program and has been releasing traine...tat. Unfortunately, plague can sweep through and ...
(Date:11/5/2009)...all/ -- Imagenetix, Inc. (OTC Bulletin Board: IAGX... and CEO of Imagenetix, will be presenting the Com... on Thursday, December 3rd, at 10:30 AM PST at the...,, LD MICRO is a by-invitation only newsletter ... in the micro-cap space. Since 2002, the firm has ...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2
...arch 25 Aethlon Medical, Inc. (OTC Bulletin Board...s the advancement of the Aethlon Hemopurifier(R) a... cure rates. The Hemopurifier(R) is a first-in-cla... in combating infectious disease through real-time...immunosuppressive proteins. In HCV care, the devi...
...ch 25 Cell Therapeutics, Inc. (CTI) (NASDAQ and M...cial Meeting of Shareholders held on Tuesday, Marc...oved the proposal to increase the number of shares... number of shares of authorized common stock), the...le for issuance under its 2007 Equity Incentive Pl...
... from the Department of Energy,s Pacific Northwest...ar,s American Chemical Society 2009 Spring Meeting...occur on Tuesday afternoon. , , Scientists are ho...k down contaminants for environmental cleanup or s...lash of UV light, titanium dioxide can do just tha...
Other Biology Technology:Aethlon Medical Announces Data Supported Strategy to Increase Hepatitis-C (HCV) Cure Rates 2Aethlon Medical Announces Data Supported Strategy to Increase Hepatitis-C (HCV) Cure Rates 3Aethlon Medical Announces Data Supported Strategy to Increase Hepatitis-C (HCV) Cure Rates 4Aethlon Medical Announces Data Supported Strategy to Increase Hepatitis-C (HCV) Cure Rates 5Cell Therapeutics, Inc. Reports Outcome of Special Meeting of Shareholders 2
(Date:11/9/2009)...avid Queller and Joan Strassmann argue in a new pa... components, from the genetic level on up, give a ...ng is an animal, a plant, a bacteria or a colony.... an organism, such as individuality or even member...achieve organismality. What is necessary, they arg...
(Date:11/9/2009).../ -- Genencor, a division of Danisco, has won the ...can Institute of Chemical Engineers (AIChE) for it...ic ethanol. Yesterday, Robert Davis, Chair of the ...don Steele, who is Marketing Director, Biomass Enz...ron Kelley, who is Senior Engineer, Biomass Applic...
(Date:11/9/2009)...ionist whose research was instrumental in adding f... and Children (WIC) food subsidy will receive the ... achievement in the field of maternal-fetal nutrit...r in the Department of Community Health Sciences a... of Public Health, will receive the award today a...
Breaking Biology News(10 mins):What is the meaning of 'one'? 2What is the meaning of 'one'? 3Genencor Wins The American Institute of Chemical Engineers (AIChE) Sustainable Energy Award For Accellerase(R) Cellulosic Ethanol Enzymes 2March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2PLC Announces That Initial Abstract for Presentation of CCM Study of RenalGuard 28R 29 at ESC 2009 Has Been Published 3B Strong Preliminary Results Se 55252 1PLC Announces That Initial Abstract for Presentation of CCM Study of RenalGuard 28R 29 at ESC 2009 Has Been Published 3B Strong Preliminary Results Se 55252 2PLC Announces That Initial Abstract for Presentation of CCM Study of RenalGuard 28R 29 at ESC 2009 Has Been Published 3B Strong Preliminary Results Se 55252 3PLC Announces That Initial Abstract for Presentation of CCM Study of RenalGuard 28R 29 at ESC 2009 Has Been Published 3B Strong Preliminary Results Se 55252 4LATINA Style Magazine Selects Aflac for Annual List of Top 50 Companies 55250 1LATINA Style Magazine Selects Aflac for Annual List of Top 50 Companies 55250 2LATINA Style Magazine Selects Aflac for Annual List of Top 50 Companies 55250 3Hair Loss Being Conquered 55248 1Hair Loss Being Conquered 55248 2
... several years ago, University of Chicago paleonto... Why bother classifying organisms according to the...olutionary dynamics, when molecular techniques had...han a few heads in the audience nodding their agre...in Geophysical Sciences, saw more work to be done....
...nithSolar, an Israeli start-up company, launched i...ased on concentrated photovoltaic (CPV) systems de...rsity of the Negev (BGU). , ZenithSolar Video ...lar Energy and Environmental Physics at BGU,s Jaco...es the new system will harvest more than 70 percen...
...ed UC San Diego Chancellor Marye Anne Fox, local s...upport for a regional partnership designed to deve... Speaking at a news conference on the UC San Dieg...ego region, now home to more than 500 biotechnolog...able energy development, as scientists from UC San...
Other Biology News:Analysis finds strong match between molecular, fossil data in evolutionary studies 2Ben-Gurion University research and technology used in new solar energy farm 2Regional partnership to develop algal biofuels gets backing of San Diego leaders 2Regional partnership to develop algal biofuels gets backing of San Diego leaders 3Regional partnership to develop algal biofuels gets backing of San Diego leaders 4Regional partnership to develop algal biofuels gets backing of San Diego leaders 5Regional partnership to develop algal biofuels gets backing of San Diego leaders 6
...e a group of enzymes involved in matrix degradatio...ase family ten exist in soluble form whereas MT-MM...T2-MMP, MT3-MMP also known as MMP14, MMP15, MMP16 ...main anchoring them to the cell surface. They have...
CD43 MicroBeads, rat from Miltenyi Biotec
... IKATUBE ULTRA TURRAX Tube Disperser System from I...ystem. It offers a cleaner, safer, and more effici...ocesses sample volumes from 2 to 15 ml inside seal...ers can choose one of 4 different tube types. Each...
RNaseAlert Lab Test Kit from Ambion
Biology Products: